Form 8-K - Current report:
SEC Accession No. 0001437749-24-035609
Filing Date
2024-11-18
Accepted
2024-11-18 16:02:13
Documents
14
Period of Report
2024-11-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20241118_8k.htm   iXBRL 8-K 24435
  Complete submission text file 0001437749-24-035609.txt   172209

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20241118.xsd EX-101.SCH 3892
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20241118_def.xml EX-101.DEF 13444
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20241118_lab.xml EX-101.LAB 17671
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20241118_pre.xml EX-101.PRE 13421
16 EXTRACTED XBRL INSTANCE DOCUMENT govx20241118_8k_htm.xml XML 4782
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241471416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)